drug

YL-15293

Phase 2updated 3mo ago

by Shanghai Yingli Pharmaceutical Co Ltd

Phase 2

community read0 votes

indications

NSCLCColorectal Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying YL-15293

phase2Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutationunknownn=150

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 34m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

YL-15293

Phase 2updated 3mo ago

by Shanghai Yingli Pharmaceutical Co Ltd

Phase 2

community read0 votes

indications

NSCLCColorectal Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying YL-15293

phase2Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutationunknownn=150

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 34m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

YL-15293

indications

all catalysts(0)

Trials studying YL-15293

News(0)

Report a data issue

comments(0)

YL-15293

indications

all catalysts(0)

Trials studying YL-15293

News(0)

Report a data issue

comments(0)